98123485 - REGENXBIO

Information

• Trademark
• 98123485

• Source

• Serial Number

  98123485

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  August 09, 2023
  a year ago

• Transaction Date

  July 13, 2024
  4 months ago

• Status Date

  April 17, 2024
  7 months ago

• Location Date

  April 17, 2024
  7 months ago

• First Use Anywhere Date

  September 01, 2014
  10 years ago

• First Use In Commerce Date

  September 01, 2014
  10 years ago

• Status Code

  641

• Current Location

  LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  LEASER, ANDREW C

• Attorney Name

  William R Samuels

  Law Office Assigned Location Code

  M80

• Owners

  • ReGenX Biosciences, LLC

Case File Statements

• GS0051: Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy

Case File Event Statements

• 4/10/2024 - 7 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/17/2024 - 7 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/12/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/7/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/17/2024 - 7 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/17/2024 - 7 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/12/2024 - 4 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA